Skip to main content

Table 2 Results of univariate analyses of potential prognostic factors for event-free survival in HCC patients

From: Assessment of preoperative exercise capacity in hepatocellular carcinoma patients with chronic liver injury undergoing hepatectomy

Variable

No. of patients

1-year survival rate (%)

3-year survival rate (%)

pvalue

Etiology

HBV

13

91.7

52.1

0.1144

HCV

33

78.1

29.0

 

NBC

15

86.7

54.2

 

AST (IU/l)

≤43

30

83.3

45.6

0.1961

>43

31

82.8

28.3

 

ALT (IU/l)

≤42

30

93.1

53.3

0.01

>42

31

73.3

22.2

 

Albumin (g/dl)

≥3.8

34

87.9

51.0

0.0226

<3.8

27

76.9

11.5

 

RBP (mg/dl)

≥3.3

32

86.7

46.9

0.0210

<3.3

29

77.8

77.8

 

BTR

≥5.0

33

87.5

53.0

0.0238

<5.0

28

77.8

16.2

 

Platelet count (104/μl)

≥15

32

85.7

52.1

0.0355

<15

29

80.6

20.9

 

AT VO2 (ml/min/kg)

≥11.5

32

90.3

42.3

0.0266

<11.5

29

75.0

33.4

 

Peak VO2 (ml/min/kg)

≥16.5

32

87.1

50.3

0.0331

<16.5

29

78.6

10.8

 

Intracellular body water (l/BW kg)

≥0.33

32

90.3

35.8

0.0129

<0.33

29

75.0

30.3

 

Body cell mass (kg/BW kg)

≥0.47

32

90.3

34,0

0.0359

<0.47

29

75.0

33.3

 

Total body protein (kg/BW kg)

≥0.14

35

85.3

36.3

0.1071

<0.14

26

78.3

32.2

 
  1. HBV hepatitis B virus, HCV hepatitis C virus, NBC non-hepatitis B or C virus, AST aspartate aminotransferase, ALT alanine aminotransferase, RBP retinol binding protein, BTR branched chain amino acid/tyrosine ratio, AT anaerobic threshold, VO 2 oxygen consumption, BW body weight.